Glaucoma Eye
25
3
5
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.0%
2 terminated out of 25 trials
85.7%
-0.8% vs benchmark
4%
1 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (25)
Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options
Testing YAG Laser Iridotomy for Primary Angle-Closure Glaucoma
Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens Sensor
Comparison Between Anterior Segment Optical Coherence Tomography and Ultrasound Bio Microscopy Parameters in Glaucoma Assessment
Tied Tube Trial in Glaucoma Surgery
Keratometric Change After XEN, Trabeculectomy and Tube Shunts
Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants
Bulbicam Validation on Glaucoma- and Cataract Patients
First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute
Assessment of the Occuity PM1 Pachymeter
MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool
MicroPulse TLT - UK Study
Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera
Augmented Macular Pigment-containing Nutraceutical and Central Visual Function
MINIject Glaucoma Implant in European Patients
Precision of the Icare200 for Measuring Intraocular Pressure
INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma
The Value of Visual Field Examination in Driving Licence.
IOP Reduction and Complications of Polymethyl Methacrylate GDD on Glaucoma Patient